Halozyme Therapeutics | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 16K 0 2024-12
Agios Pharmaceuticals USD 74K 1000 2025-03
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Amarin USD 305.2M 156K 2024-09
Amgen USD 33.58B 45M 2025-03
Baxter International USD 683M 0 2024-12
Cytokinetics USD 119K 1000 2025-03
DBV Technologies USD 10.98M 1000 2024-09
Eli Lilly USD 592.6M 200K 2025-03
Halozyme Therapeutics USD 123K 0 2025-03
Indivior 62M 0 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
MannKind USD 3.03M 276K 2024-12
Pfizer USD 481M 1000K 2025-03
United Therapeutics USD 800K 0 2025-03



Halozyme Therapeutics Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.